NCT04970472 Bio Clinical Collection of Urothelial Carcinoma
| NCT ID | NCT04970472 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Hospital, Toulouse |
| Condition | Urothelial Carcinoma |
| Study Type | OBSERVATIONAL |
| Enrollment | 1,000 participants |
| Start Date | 2021-11-16 |
| Primary Completion | 2026-07-14 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 1,000 participants in total. It began in 2021-11-16 with a primary completion date of 2026-07-14.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this study is to collect tumor samples, urines, stool and blood from patients with urothelial carcinoma. These samples will be stored in a secure and confidential laboratory of the Toulouse University Hospital.
Eligibility Criteria
Inclusion Criteria: * Adult \>18 years old * Patient with suspected or diagnosed Urothelial carcinoma * Patients who are willing to consent for this protocol. Exclusion Criteria: * Pregnant or breastfeeding patients * Patients under 18 years old * Patients under guardianship or curators * Patients unable to sign a free and informed consent
Contact & Investigator
Mathieu Roumiguie, MD, PhD
PRINCIPAL INVESTIGATOR
University Hospital, Toulouse
Frequently Asked Questions
Who can join the NCT04970472 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 99 Years, studying Urothelial Carcinoma. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04970472 currently recruiting?
Yes, NCT04970472 is actively recruiting participants. Contact the research team at roumiguie.m@chu-toulouse.fr for enrollment information.
Where is the NCT04970472 trial being conducted?
This trial is being conducted at Toulouse, France.
Who is sponsoring the NCT04970472 clinical trial?
NCT04970472 is sponsored by University Hospital, Toulouse. The principal investigator is Mathieu Roumiguie, MD, PhD at University Hospital, Toulouse. The trial plans to enroll 1,000 participants.